Cytosorbents (CTSO) Change in Acquisitions & Divestments (2015 - 2016)
Cytosorbents' (CTSO) quarterly Change in Acquisitions & Divestments came in at $249000.0 in Q3 2016, down 83.33% on a YoY basis from $1.5 million in Q4 2015, and down 87.18% quarter-over-quarter from $1.9 million in Q2 2016.
Powered by 
Analysis
Cytosorbents (CTSO) Change in Acquisitions & Divestments (2015 - 2016) Analysis & Trends
Cytosorbents (CTSO) has reported Change in Acquisitions & Divestments for 2 consecutive years, with $249000.0 the latest figure, recorded in Q3 2016.
- For the quarter ending Q3 2016, Change in Acquisitions & Divestments fell 83.33% year-over-year to $249000.0; the trailing twelve-month figure through Dec 2017 stood at $2.2 million (changed 0.0% YoY), and the FY2016 full-year result was $2.2 million, down 59.64% from the prior year.
- Change in Acquisitions & Divestments fell to $249000.0 in Q3 2016 per CTSO's latest filing, from $1.9 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $1.9 million in Q2 2016 and bottomed at $249000.0 in Q3 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2016 | 249,000.00 |
| Jun 30, 2016 | 1.94 Mn |
| Dec 31, 2015 | 1.49 Mn |
| Sep 30, 2015 | 1.49 Mn |
| Jun 30, 2015 | 1.20 Mn |
| Mar 31, 2015 | 1.25 Mn |